Crucial role of interferon consensus sequence binding protein, but neither of interferon regulatory factor 1 nor of nitric oxide synthesis for protection against murine listeriosis

Journal of Experimental Medicine

Volumn 185, Issue 5, 1997, Pages 921-931

  Fehr, Thomas ^a   Schoedon, Gabriele ^b   Odermatt, Bernhard ^b   Holtschke, Thomas ^c   Schneemann, Markus ^b   Bachmann, Martin F ^a   Mak, Tak W ^d   Horak, Ivan ^c   Zinkernagel, Rolf M ^a  

^a INSTITUTE OF EXPERIMENTAL IMMUNOLOGY   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c LEIBNIZ INSTITUT FÜR MOLEKULARE PHARMAKOLOGIE   (Germany)

^d PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; GAMMA INTERFERON; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; INTERFERON REGULATORY FACTOR; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; REGULATOR PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; DRUG MECHANISM; IMMUNE RESPONSE; IMMUNOMODULATION; INFECTION PREVENTION; LISTERIOSIS; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING;

ADOPTIVE TRANSFER; ANIMALS; CARRIER PROTEINS; CELL TRANSPLANTATION; CELLS, CULTURED; DISEASE SUSCEPTIBILITY; DNA-BINDING PROTEINS; IMMUNITY, NATURAL; INTERFERON REGULATORY FACTOR-1; INTERFERON REGULATORY FACTOR-2; INTERFERON REGULATORY FACTORS; INTERFERON TYPE II; LISTERIA INFECTIONS; LIVER; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MODELS, BIOLOGICAL; NITRIC OXIDE; PHOSPHOPROTEINS; REACTIVE OXYGEN SPECIES; REPRESSOR PROTEINS; RESPIRATORY BURST; SIGNAL TRANSDUCTION; SPECIES SPECIFICITY; SPLEEN; TRANSCRIPTION FACTORS;

EID: 0030896666     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.185.5.921     Document Type: Article

References (67)

1. Kaufmann, S.H.E. 1993. Immunity to intracellular bacteria. Annu. Rev. Immunol. 11:129-163.
2. Conlan, J.W., and R.J. North. 1991. Neutrophil-mediated dissolution of infected host cells as a defense strategy against a facultative intracellular bacterium. J. Exp. Med. 174:741-744.
3. Hiromatsu, K., Y. Yoshikai, G. Matsuzaki, S. Ohga, K. Muramori, K. Matsumoto, J.A. Bluestone, and K. Nomoto. 1992. A protective role of gamma/delta T cells in primary infection with Listeria monocytogenes in mice. J. Exp. Med. 175:49-56.
4. Bancroft, G.J., R.D. Schreiber, and E.R. Unanue. 1991. Natural immunity: a T-cell-independent pathway of macrophage activation, defined in the scid mouse. Immunol. Rev. 124:5-24.
5. Wherry, J.C., R.D. Schreiber, and E.R. Unanue. 1991. Regulation of gamma Interferon production by natural killer cells in scid mice: roles of tumor necrosis factor and bacterial stimuli. Infect. Immun. 59:1709-1715.
6. Portnoy, D.A., R.D. Schreiber, P. Connelly, and L.G. Tilney. 1989. Gamma Interferon limits access of Listeria monocytogenes to the macrophage cytoplasm. J. Exp. Med. 170:2141-2146.
7. Bancroft, G.J., R.D. Schreiber, G.C. Bosma, M.J. Bosma, and E.R. Unanue. 1987. A T cell-independent mechanism of macrophage activation by interferon-gamma. J. Immunol. 139:1104-1107.
8. Mielke, M.E.A., S. Ehlers, and H. Hahn. 1988. T-cell subsets in delayed-type hypersensitivity, protection, and granuloma formation in primary and secondary Listeria infection in mice: superior role of Lyt-2+ cells in acquired immunity. Infect. Immun. 56:1920-1925.
9. Harty, J.T., R.D. Schreiber, and M.J. Bevan. 1992. CD8 T cells can protect against an intracellular bacterium in an interferon gamma-independent fashion. Proc. Natl. Acad. Sci. USA. 89:11612-11616.
10. Kägi, D., B. Ledennann, K. Bürki, H. Hengartner, and R.M. Zinkernagel. 1994. CD8+ T cell-mediated protection against an intracellular bacterium by perforin-dependent cytotoxicity. Eur. J. Immunol, 24:3068-3072.
11. Dalton, D.K., S. Pitts-Meek, S. Keshav, I.S. Figari, A. Bradley, and T.A. Stewart. 1993. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science (Wash. DC). 259:1739-1742.
12. Huang, S., W. Hendriks, A. Althage, S. Hemmi, H. Bluethmann, R. Kamijo, J. Vilcek, R.M. Zinkernagel, and M. Aguet. 1993. Immune response in mice that lack the interferon-gamna receptor [see comments], Science (Wash. DC). 259:1742-1745.
13. Rothe, J., W. Lesslauer, H. Lotscher, Y. Lang, P. Koebel, F. Kontgen, A. Althage, R. Zinkernagel, M. Steinmetz, and H. Bluethmann. 1993. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature (Lond.). 364:798-802.
14. Lepay, D.A., R.M. Steinman, C.F. Nathan, H.W. Murray, and Z.A. Cohn. 1985. Liver macrophages in murine listeriosis J. Exp. Med. 161:1503-1512.
15. Peck, R. 1989. Gamma interferon induces monocyte killing of Listeria monocytogenes by an oxygen-dependent pathway; alpha- or beta-interferons by oxygen-independent pathways. J. Leukoc. Biol. 46:434-440.
16. van Dissel, J.T., J.J.M. Stikkelbroek, and R. van Furth. 1993. Differences in the rate of intracellular killing of catalase-negative and catalase-positive Listeria moncytogenes by normal and interferon-gamma-activated macrophages. Scand. J Immunol. 37:443-446.
17. Leenen, P.J.M., B.P. Canono, D.A. Drevets, J.S.A. Voerman, and P.A. Campbell. 1994. TNF-α and IFN-γ stimulate a macrophage precursor cell line to kill Listeria moncytogenes in a nitric oxide-independent manner. J. Immunol. 154:5141-5147.
18. Bläuer, F., P. Groscurth, M. Schneemann, G. Schoedon, and A. Schaffner. 1995. Modulation of the antilisterial activity of human blood-derived macrophages by activating and deactivating cytokines. J. Interferon Cytokine. Res. 15:105-114.
19. Inoue, S., S.-I. Itagaki, and F. Amano. 1995. Intracellular killing of Listeria monocytogenes in the J774.1 macrophage-like cell line and the lipopolysaccharide (LPS)-resistant mutant LPS1916 cell line defective in the generation of reactive oxygen intermediates after LPS treatment. Infect. Immun. 63: 1876-1886.
20. Beckerman, K.P., H.W. Rogers, J.A. Corbett, R.D. Schreiber, M.L. McDaniel, and E.R. Unanue. 1993. Release of nitric oxide during the T cell-independent pathway of macrophage activation. J. Immunol. 150:888-895.
21. Flesch, I.E.A., J.H. Hess, and S.H.E. Kaufmann. 1994. NADPH diaphorase staining suggests a transient and localized contribution of nitric oxide to host defence against an intracellular pathogen in situ. Int. Immunol. 6:1751-1757.
22. Boockvar, K.S., D.L. Granger, R.M. Poston, M. Maybodi, M.K. Washington, J.B. Hibbs, Jr., and R.L. Kurlander. 1994. Nitric oxide produced during murine listeriosis is protective. Infect. Immun. 62:1089-1100.
23. MacMicking, J.D., C. Nathan, G. Hom, N. Chartrain, D.S. Fletcher, M. Trumbauer, K. Stevens, Q.-w. Xie, K. Sokol, N. Hutchinson et al. 1995. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell. 81:641-650.
24. Willianis, B.R.G. 1991. Transcriptional regulation of interferon-stimulated genes. Eur. J Biochem. 200:1-11.
25. Sen, G.C., and P. Lengyel. 1992. The interferon system; a bird's eye view of its biochemistry. J. Biol. Client. 267:5017-5020.
26. Müller, U., U. Steinhoff, L.F. Reis, S. Hemmi, J. Pavlovic, R.M. Zinkernagel, and M. Aguet. 1994. Functional role of type I and type II interferons in antiviral defense. Science (Wash. DC). 264:1918-1921.
27. van den Broek, M.F., U. Müller, S. Huang, M. Aguet, and R.M. Zinkernagel. 1995. Antiviral defence in mice lacking both α/β and γ interferon receptors. J. Virol. 69:4792-4796.
28. van den Broek, M.F., U. Müller, S. Huang, R.M. Zinkernagel, and M. Aguet. 1995. Immune defence in mice lacking type I and/or type II Interferon receptors. Immunol. Rev. 148: 5-18.
29. Levy, D.E., D.J. Lew, T. Decker, D.S. Kessler, and J.E. Darnell, Jr. 1990. Synergistc interaction between interferon-alpha and interferon-gamma through induced synthesis of one sub-unit of the transcription factor ISGF3. EMBO (Eur. Mol. Biol. Organ.) J. 9:1105-1111.
30. Coccia, E.M., G. Marziali, E. Stellacci, E. Perrocti, R. Ilari, R. Orsatti, and A. Battistini. 1995. Cells resistant to interferon-beta respond to interferon-gamma via the Stat1-IRF-1 pathway. Virology, 211:113-122.
31. Miyamoto, M., T. Fujita, Y. Kimura, M. Maruyama, H. Harada, Y. Sudo, T. Miyata, and T. Taniguchi. 1988. Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-beta gene regulatory elements. Cell. 54:903-913.
32. Meraz, M.A., J.M. White, K.C.F. Sheehan, E.A. Bach, S.J. Rodig, A.S. Dighe, D.H. Kaplan, J.K. Riley, A.C. Greenlund, D. Campbell, et al. 1996. Targeted disruption of the Statl gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell. 84:431-442.
33. Durbin, J.E., R. Hackenmiller, M.C. Simon, and D.E. Levy. 1996. Targeted disruption of the mouse Statl gene results in compromised innate immunity to viral disease. Cell. 84: 443-450.
34. Driggers, P.H., D.L. Ennist, S.L. Gleason, W.-H. Mak, M.S. Marks, B.-Z. Levi, J.R. Flanagan, E. Appella, and K. Ozato. 1990. An Interferon gamma-regulated protein that binds the interferon-inducible enhancer element of major histocompatibility complex class I genes. Proc. Natl. Acad. Sci. USA. 87: 3743-3747.
35. Politis, A.D., J. Sivo, P.H. Driggers, K. Ozato, and S.N. Vogel. 1992. Modulation of interferon consensus sequence binding protein mRNA in murine peritoneal macrophages. J. Immunol. 148:801-807.
36. Holtschke, T., J. Löhler, Y. Kanno, T. Fehr, N. Giese, F. Rosenbauer, J. Lou, K.-P. Knobeloch, L. Gabriele, J.F. Waring et al. 1996. Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene. Cell. 87:307-317.
37. Harada, H., T. Fujita, M. Miyamoto, Y. Kimura, M. Maruyama, A. Furia, T. Miyata, and T. Taniguchi. 1989. Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell. 58:729-739.
38. Nelson, N., M.S. Marks, P.H. Driggers, and K. Ozato. 1993. Interferon consensus sequence-binding protein, a member of the interferon regulatory factor family, suppresses interferon-induced gene transcription. Mol. Cell Biol. 13:588-599.
39. Matsuyama, T., T. Kimura, M. Kitagawa, K. Pfeffer, T. Kawakami, N. Watanabe, T.M. Kündig, R. Amkawa, K. Kishihara, A. Wakeham et al. 1993. Targeted disruption of IRF-1 or IRF-2 results in abnormal typo 1 IFN gene induction and aberrant lymphocyte development. Cell. 75:83-97.
40. Kimura, T., K. Nakayanu, J. Penninger, M. Kitagawa, H. Harada, T. Matsuyama, N. Tanaka, R. Kamijo, J. Vilcek, T.W. Mak, and T. Taniguchi. 1994. Involvement of the IRF-1 transcription factor in antiviral responses to interferons. Science (Wash. DC). 264:1921-1923.
41. Schoedon, G., M. Schneemann, S. Hofer, L. Guerrero, N. Blau, and A. Schaffner. 1993. Regulation of the L-arginine-dependent and tetrahydrobiopterin-dependent biosynthesis of nitric oxide in murine macrophages. Eur. J. Biochem. 213: 833-839.
42. 2 by "resting" and lymphokine-activated human blood-derived macrophages. J. Immunol. 142:2813-2820.
43. Schaffner, A., and P. Rellstab. 1988. Gamma-interferon restores listericidal activity and concurrently enhances release of reactive oxygen metabolites in dexamethasone-treated human monocytes. J. Clin. Invest. 82:913-919.
44. Bovolenta, C., P.H. Driggers, M.S. Marks, J.A. Medin, A.D. Politis, S.N. Vogel, D.E. Levy, K. Sakaguchi, E. Appella, J.E. Coligan et al. 1994. Molecular interactions between interferon consensus sequence binding protein and members of the interferon regulatory factor family. Proc. Natl. Acad. Sci. USA. 91:5046-5050.
45. Weisz, A., S. Kirchhoff, and B.-Z. Levi. 1994. IFN consensus sequence binding protein (ICSBP) is a conditional repressor of IFN inducible promoters. Int. Immunol. 6:1125-1131.
46. Emmerling, P., H. Finger, and H. Hof. 1977. Cell-mediated resistance to infection with Listeria monocytogenes in nude mice. Infect. Immun. 15:382-385.
47. Shinkai, Y., G. Rathbun, K.P. Lam, E.M. Oltz, V. Stewart, M. Mendelsohn, J. Charron, M. Datta, F. Young, and A.M. Stall, 1992. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell. 68: 855-867.
48. Kamijo, R., H. Harada, T. Matsuyama, M. Bosland, J. Gerecitano, D. Shapiro, J. Le, S.I. Koh, T. Kimura, S.J. Green et al. 1994. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science (Wash. DC). 263: 1612-1615.
49. Martin, E., C. Nathan, and Q.-w. Xie. 1994. Role of interferon regulatory factor 1 in induction of nitric oxide synthase. J. Exp. Med. 180:977-984.
50. Kamijo, R., D. Shapiro, J. Le, S. Huang, M. Aguet, and J. Vilcek. 1993. Generation of nitric oxide and induction of major histocompatibility complex class II antigen in macrophages from mice lacking the interferon gamma receptor. Proc. Natl. Acad. Sci. USA. 90:6626-6630.
51. Salkowski, C.A., S.A. Barber, G.R. Detore, and S.N. Vogel. 1996. Differential dysregulation of nitric oxide production in macrophages with targeted disruptions in IFN regulatory factor-1 and -2 genes. J. Immunol. 157:3107-3110.
52. Berche, P.A. 1985. Resistance to listeriosis in two lines of mice genetically selected for high and low antibody production. Immunology. 56:707-715.
53. Barber, S.A., M.J. Fultz, C.A. Salkowski, and S.N. Vogel. 1995. Differential expression of interferon regulatory factor 1 (IRF-1), IRF-2, and interferon consensus sequence binding protein genes in lipopolysaccharide (LPS)-responsive and LPS-hyporesponsive macrophages. Infect. Immun. 63:601-608.
54. Dabiri, G.A., J.M. Sanger, D.A. Portnoy, and F.S. Southwick, 1990. Listeria monocytogenes moves rapidly through the host-cell cytoplasm by inducing directional actin assembly. Proc. Natl. Acad. Sci. USA. 87:6068-6072.
55. Stenger, S., H. Thüring, M. Röllinghoff, and C. Bogdan. 1994. Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major. J. Exp. Med. 180:783-793.
56. Wei, X.Q., I.G. Charles, A. Smith, J. Ure, G.J. Feng, F.P. Huang, D. Xu, W. Muller, S. Moncada, and F.Y. Liew. 1995. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature (Lond.). 375:408-411.
57. Khan, I.A., T. Matsuura, S. Fonseka, and L.H. Kasper. 1996. Production of nitric oxide (NO) is not essential for protection against acute Toxoplasma gondii infection in IRF-1-/-mice. J. Immunol. 156:636-643.
58. Samsom, J.N., J.A. Langermans, P.H. Groeneveld, and R. van Furth. 1996. Acquired resistance against a secondary infection with Listeria monocytogenes in mice is not dependent on reactive nitrogen intermediates. Infect. Immun. 64:1197-1202.
59. Gregory, S.H., E.J. Wing, R.A. Hoffman, and R.L. Simmons. 1993. Reactive nitrogen intermediates suppress the primary immunologic response to Listeria. J. Immunol. 150: 2901-2909.
60. Aggarwal, B.B., T.E. Eessalu, and P.E. Hass. 1985. Characterization of receptors for human tumor necrosis factor and their regulation by gamma-interferon. Nature (Lond.) 318:665-667.
61. Collart, M.A., D. Belin, J.-D. Vassalli, S. de Kossodo, and P. Vassalli. 1986. Gamma-interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin 1, and urokinase genes, which are controlled by short-lived repressors J. Exp. Med. 164:2113-2118.
62. Akira, S., K. Yoshida, T. Tanaka, T. Taga, and T. Kishimoto. 1995. Targeted disruption of the IL-6 related genes: gp130 and NF-IL-6. Immunol. Rev. 148:221-253.
63. Tanaka, T., S. Akira, K. Yoshida, M. Umemoto, Y. Yoneda, N. Shirafuji, H. Fujiwara, S. Suematsu, N. Yoshida, and T. Kishimoto. 1995. Targeted disruption of the NF-IL6 gene discloses its essential role in bacteria killing and tumor cytotoxicity by macrophages. Cell 80:353-361.
64. Alford, C.E., T.E. King, Jr., and P.A. Campbell. 1991. Role of transferrin, transferrin receptors, and iron in macrophage listericidal activity. J. Exp. Med. 174:459-466.
65. Ampel, N.M., D.B. Van Wyck, M.L. Aguirre, D.G. Willis, and R.A. Popp. 1989. Resistance to infection in murine beta-Thalassemia. Infect. Immun. 57:1011-1017.
66. Lieschke, G.J., D. Grail, G. Hodgson, D. Metcalf, E. Stanley, C. Cheers, K.J. Fowler, S. Basu, Y.F. Zhan, and A.R. Dunn. 1994. Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood. 84:1737-1746.
67. Fujita, T., L.F. Reis, N. Watanabe, Y. Kimura, T. Taniguchi, and J. Vilcek. 1989. Induction of the transcription factor IRF-1 and interferon-beta mRNAs by cytokines and activators of second-messenger pathways. Proc. Natl. Acad. Sci. USA. 86:9936-9940.